Şaban KARAYAĞIZ, Mustafa BAŞTÜRK

Alexithymia levels in patients with unipolar and bipolar depression and the effect of alexithymia on both severity of depression symptoms and quality of life

Amaç: Bu çalışmada unipolar depresyon (UD), bipolar afektif bozukluk depresif nöbet (BAB-D) olguları ve sağlıklı kontrollerin aleksitimi düzeylerini karşılaştırmak, bununla ilişkili olarak aleksitimi puanlarının depresif belirti şiddeti ve yaşam kalitesi puanları üzerine etkisini incelemek amaçlanmıştır. Yöntem: Çalışmada DSM-IV-TR ölçütlerine göre ruhsal durum muayenesi ile UD tanısı konan 118 hasta, BAB depresif nöbette olan 48 hasta olgu grubunu oluşturmuştur. Herhangi bir psikiyatrik bozukluğu olmayan 96 kişi kontrol grubu olarak alınmıştır. Toplam 262 kişi çalışmaya alınmıştır. Veri toplama aracı olarak Sosyodemografik ve Klinik Veri Formu, Hamilton Depresyon Derecelendirme Ölçeği (HDDÖ), Beck Depresyon Ölçeği (BDÖ), Toronto Aleksitimi Ölçeği (TAÖ-20) ve SF-36 Yaşam Kalitesi Ölçeği kullanılmıştır. Sonuçlar: UD, BAB-D ve sağlıklı kontrol gruplarının yaş ortalamaları, cinsiyetleri, medeni durumları, yaşadıkları coğrafi bölge ve gelir düzeyleri açısından birbirine benzerdi. UD, BAB-D ve sağlıklı kontrol gruplarına ait HDDÖ, BDÖ, TAÖ-20 ve SF-36 ölçek puanları arasında istatistiksel olarak anlamlı fark vardı. UD ve BAB-D hasta gruplarında tüm ölçeklerde ortalama grup puanları kontrol grubundan daha yüksekti. UD ile BAB-D gruplarının dört ölçek için ortalama puanları birbirine benzerdi. Hem UD, hem de BAB-D hasta gruplarında TAÖ-20 ile HDDÖ ve BDÖ arasında pozitif yönde anlamlı ilişki, SF-36 ile arasında ise negatif yönde anlamlı bir ilişki bulundu. Sonuç olarak UD ve BAB-D hastalarının aleksitimi düzeylerinin kontrol grubundan yüksek olduğu; yaşam kalitesi puanlarının kontrol grubundan daha düşük olduğu saptanmıştır. Tüm olguların aleksitimi puanlarının artışı ile depresif belirti şiddetlerinin artış gösterdiği, yaşam kaliteleri puanlarında ise azalma olduğu bulunmuştur. Elde ettiğimiz sonuçlar depresif bozukluklarda aleksitimi varlığının önemli olduğunu gösterse de, BAB-D ve UD hastaları arasında aleksitimi düzeyinin farklı olmadığı saptandı.

Bipolar ve unipolar depresyonda aleksitimi düzeyleri ve depresif belirti şiddeti ile yaşam kalitesi üzerine etkisi

Objective: Aims of this study are to compare the alexithymia scores of patients with unipolar depression (UD), bipolar affective disorder depressive episode (BAD-D) and healthy controls, to explore the effects of alexithymia scores on both severity of depression symptoms and quality of life. Methods: Case group of the study is consisted of one hundred and eighteen UD diagnosed, forty eight BAD-depression diagnosed patients, based on DSM-IV-TR criteria. Control group of the study is consisted of ninety six people who had no history of psychiatric disease. Overall, 262 people had involved in the study. Sociodemographic and Clinical Data Form, Hamilton Rating Scale for Depression (HRDS), Beck Depression Inventory (BDI), Toronto Alexithymia Scale (TAS-20) and SF-36 Quality of Life Scale are used for acquiring information of the patients. Results: Mean of age, gender, marital status, place for living, level of income of UD, BAD-D and control groups were similar. Statistically significant differences were observed in between UD, BAD-D and control groups, in terms of HRDS, TAS-20 and SF-36 scores. Mean group scores of UD and BAD-D group were higher than controls, in terms of all scales. However, mean points of UD and BAD-D groups were similar in terms of four scales. Patients with UD and BAD-D had positive relationship with TAS-20, BRDS and BDI; negative relationship between SF-36, significantly. In conclusion, it is found that alexithymia scores of UD and BAD-D groups were higher; quality of life scores were lower than controls. It is also observed that patients with higher alexithymia scores have more severe depressive symptoms and having a less sense of quality of life. Although our findings indicate that presense of alexithymia is important in depressive disorders, however no difference were found between alexithymia scores in patients with UD and BAD-D. Discussion: Alexithymia scores of all groups had positively related with depression, negatively related with quality of life. Our findings showed that, alexithymia is an important factor to the diagnosis of depressive disorders, however alexithymia is not a marker to make differential diagnosis of BAD-D and UD.

PDF

___

1. Ozkorumak E, Gulec H, Kose S, Borckardt J, Sayar K. Extra medical ways of help-seeking behaviour in patients with depression: can alexithymia be a contributing factor? J Clin Psychiat 2006; 9:161-169.
2. Şaşıoğlu M, Gülol Ç, Tosun A. The concept of alexithymia. Curr Approaches Psychiatry 2013; 5:507-527.
3. Saarijarvi S, Salminen JK, Toikka T. Alexithymia and depression: a 1-year follow-up study in outpatients with major depression. J Psychosom Res 2001; 51:729-733.
4. Schmidt U, Jiwany A, Treasure J. A controlled study of alexithymia in eating disorders. Compr Psychiatry 1993; 34:54-58.
5. Pinard L, Negrete JC, Annable L, Audet N. Alexithymia in substance abusers: persistence and correlates of variance. Am J Psychiatry 1996; 5:32-39.
6. Fukunishi I, Kikuchi M, Takubo M. Changes in scores on alexithymia over a period of psychiatric treatment. Psychol Rep 1997; 80:483-489.
7. Honkalampi K, Hintikka J, Saarinen P, Lehtonen J, Viinamaki H. Is alexithymia a permenant feature in depressed patients? Results from a 6-month follow-up study. Psychother Psychosom 2000; 69:303-308.
8. Honkalampi K, Hintikka J, Koivumaa-Honkanen H, Antikainen R, Haatainen K, Viinamaki H. Longterm alexithymic features indicate poor recovery from depression and psychopathology. A six-year follow-up. Psychother Psychosom 2007; 76:312- 314.
9. Yildirim MK, Ozkan M, Ozkan S, Oflaz SB, Gelincik A, Buyukozturk S. Relationship among alexithymia, anxiety, and depression in patients with chronic idiopathic urticaria. Nobel Med 2012; 8:46- 51.
10. Mattila AK, Salminen JK, Nummi T, Joukamaa M. Age ıs strongly associated with alexithymia in the general population. J Psychosom Res 2006; 61(5):629-635.
11. Muldoon MF, Barger SD, Flory JD, Manuck SB. What are quality of life instruments measuring? BMJ 1998; 316:542-545.
12. Kim-Schluger L, Florman SS, Schiano T, O'Rourke M, Gagliardi R, Drooker M, et al. Quality of life after lobectomy for adult liver transplantation. Transplantation 2002; 73:1593-1597.
13. Berlim MT, Mattevi BS, Fleck MP. Depression and quality of life among depressed Brazilian outpatients. Psychiatr Serv 2003; 54(2):254.
14. Demyttenaere K, Fruyt JD, Huygens R. Measuring quality of life in depression. Curr Approaches Psychiatry 2002; 15:89-92.
15. Hamilton M. Rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62.
16. Akdemir A, Örsel S, Dağ İ, Türkçapar H, İşcan N, Özbay H. Hamilton depresyon derecelendirme ölçeği (HDDÖ)'nin geçerliliği, güvenilirliği ve klinikte kullanımı. 3P Dergisi 1996; 4:251-259.
17. Beck AT. An inventory for measuring depression. JAMA Psychiatry 1961; 4:561-71.
18. Hisli N. Validation and safety study of beck depression inventory in undergrads. J Psychol 1989; 7:3-13.
19. Bagby RM, Parker JD, Taylor GJ. The twenty-item toronto alexithymia scale--ı. Item selection and cross-validation of the factor structure. J Psychosom Res 1994; 38:23-32.
20. Gulec H, Kose S, Yazıcı GM. Reliability and factorial validity of the Turkish version of the 20-item Toronto alexithymia scale (TAS-20), BCP 2009; 19:214-220.
21. Koçyiğit H, Aydemir Ö, Fişek G. Kısa form-36 (KF- 36)'nın Türkçe versiyonunun güvenirliliği ve geçerliliği. İlaç ve Tedavi Derg 1999; 12:102-106.
22. Motan I, Gencoz T. The relationship between the dimensions of alexithymia and the intensity of depression and anxiety. Turk J Psychiat 2007; 18:333-343.
23. Marchesi C, Ossola P, Tonna M, De Panfilis C. The TAS-20 more likely measures negative affects rather than alexithymia itself in patients with major depression, panic disorder, eating disorders and substance use disorders. Compr Psychiatry 2014; 55: 972-978.
24. Aydın A. Selvi Y. Özdemir, PG. Depresyon hastalarında aleksitiminin bedenselleştirme ve uyku kalitesi üzerine etkisi. Arch Neuropsychiatr 2013; 50:65-69.
25. Parker JD. The alexithymia construct: Relationship with sociodemographic variables and intelligence. Compr Psychiatry 1989; 30:434-440.
26. Yurt E. Aleksitimi, Şizofreni Hastalarında; Negatif Belirtiler, İlaç Yan Etkileri, Depresyon ve İç Görü ile İlişkisi. Yayımlanmamış Uzmanlık Tezi, İstanbul, T.C. Sağlık Bakanlığı Bakırköy Ord. Prof. Mazhar Osman Ruh Sağlığı ve Sinir Hastalıkları Hastanesi, 2006.
27. Li S. Zhang B. Guo Y. Zhang J. The association between alexithymia as assessed by the 20-item toronto alexithymia scale and depression: A metaanalysis. Psychiatry Res 2015; 227:1-9.
28. Celikel FC, Kose S, Erkorkmaz U, Sayar K, Cumurcu BE, Cloninger CR. Alexithymia and temperament and character model of personality in patients with major depressive disorder. Compr Psychiatry 2010; 51:64-70.
29. Rybakowski JK, Dyson WL, Amsterdam JD. Alexithymia and somatic conditions in patients with affective illnesses during lithium prophylaxis. Psychother Psychosom 1988; 49:1-5.
30. Stankovi? ?. Nikoli?-Balkoski G. Leposavi? L, Popovi? L. Perception of quality of life and social adjustment of patients with recurrent depression. Srp Arh Celok Lek 2006; 134:369-374.
31. Ardal G, Lund A, Hammar A. Health-related quality of life in recurrent major depressive disorder-A 10-year follow-up study. Nord J Psychiatry 2013; 67:339-343.
32. Zikic O, Tosic-Golubovic S, Slavkovic V. Quality of life of patients with unipolar depression. Medicinski Pregled 2010; 63:113-116.
33. Gutiérrez-Rojas L, Gurpegui M, Ayuso-Mateos JL, Gutiérrez-Ariza JA, Ruiz-Veguilla M, Jurado D. Quality of life in bipolar disorder patients: a comparison with a general population sample. Bipolar Disord 2008; 10:625-634.
34. Sierra P, Livianos L, Rojo L. Quality of life for patients with bipolar disorder: relationship with clinical and demographic variables. Bipolar Disord 2005; 7:159-165.
35. Hayhurst H, Palmer S, Abbott R, Johnson T, Scott J. Measuring health-related quality of life in bipolar disorder: relationship of the EuroQol (EQ-5D) to condition-specific measures. Qual Life Res 2006; 15:1271-1280.
36. Vojta C, Kinosian B, Glick H, Altshuler L, Bauer MS. Self-reported quality of life across mood states in bipolar disorder. Compr Psychiatry 2001; 42:190-195.
37. Berlim MT, Pargendler J, Caldieraro MA, Almeida EA, Fleck MP, Joiner TE. Quality of life in unipolar and bipolar depression: are there significant differences? J Nerv Ment Dis 2004; 192:792-795.